Improved transdermal formulations

Details Improved transdermal formulations Improved transdermal formulations

A - Human Necessities

61

K

A61K 47/12 (2006.01) A61K 9/06 (2006.01) A61K 9/70 (2006.01) A61K 31/40 (2006.01) A61K 47/14 (2006.01)

Patent

CA 2115831

2115831 9303767 PCTABS00020 An improved transdermal delivery composition is provided comprising a low molecular weight fatty acid, characterised in that it further comprises a long chain fatty acid or a long chain fatty acid lower alkyl ester, wherein the long chain is a C13 to C21 chain and preferably contains at least one cis-olefinic bond. Preferred long chain components are oleic acid and ethyl oleate while the preferred low molecular weight fatty acid is propionic acid. The compositions are particularly effective at transdermally delivering physostigmine and its analogues in a stable dosaged manner.

Affiliated with

Also associated with

Rating

Improved transdermal formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved transdermal formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved transdermal formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1413161